Wesana Health Holdings Inc. WSNAF

WSNAF Company Overview

Wesana Health Holdings Inc. is a Canadian-based health and life sciences company that focused on psychedelic-assisted therapies, mental health treatment platforms, and neurological wellness initiatives. The company operated within the broader behavioral health, biotechnology, and emerging psychedelic medicine industries, with an emphasis on developing therapies and care models intended to address conditions such as traumatic brain injury (TBI), depression, anxiety, and substance use disorders. Public disclosures and market filings indicate that the company pursued an integrated model combining clinical treatment services, research partnerships, and intellectual property development tied to psychedelic compounds and mental health protocols.

The company’s primary business activities historically included psychedelic therapy clinic operations, research collaborations, and investment in treatment infrastructure associated with ketamine-assisted and psychedelic-assisted care. Wesana Health sought to position itself as an early participant in the regulated psychedelic healthcare market by combining clinical services with therapeutic protocol development. The company evolved through acquisitions and strategic partnerships following its public market debut, although later public filings and disclosures reflected operational restructuring, financial constraints, and strategic reassessment. Certain aspects of its current operating scale and commercial activity are inconclusive based on available public sources.